Evidence map›Paper›PMID 25421714›Full record

ArticleMolecular and cellular biology2015

NCoR1 and SMRT play unique roles in thyroid hormone action in vivo.

Hiroaki Shimizu, Inna Astapova, Felix Ye, Martin Bilban, Ronald N Cohen, Anthony N Hollenberg

Open access · bronzeAbstract read
In one paragraph

Article in Molecular and cellular biology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 52 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Thyroid Hormones and Co-workers: An Overview.Methods in molecular biology (Clifton, N.J.) · 2025
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Balanced control of thermogenesis by nuclear receptor corepressors in brown adipose tissue.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Hiroaki ShimizuDivision of Endocrinology, Diabetes and Metabolism, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston Massachusetts, USA.
Inna AstapovaDivision of Endocrinology, Diabetes and Metabolism, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston Massachusetts, USA.
Felix YeDivision of Endocrinology, Diabetes and Metabolism, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston Massachusetts, USA.
Martin BilbanDepartment of Laboratory Medicine and Core Facility Genomics, Medical University of Vienna, Vienna, Austria.
Ronald N CohenSection of Endocrinology, University of Chicago, Chicago, Illinois, USA roncohen@medicine.bsd.uchicago.edu thollenb@bidmc.harvard.edu.
Anthony N HollenbergDivision of Endocrinology, Diabetes and Metabolism, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston Massachusetts, USA roncohen@medicine.bsd.uchicago.edu thollenb@bidmc.harvard.edu.
Beth Israel Deaconess Medical Center · USHarvard University · USMedical University of Vienna · ATUniversity of Chicago · US

Funding

Pilot and Feasibility ProgramP30DK020595 · NIDDK · UNIVERSITY OF CHICAGO · PI Matthew J Brady · 2013 to 2026
$20.9M
Re-Engineering Translational Research at the University of ChicagoUL1TR000430 · NCATS · UNIVERSITY OF CHICAGO · PI SOLWAY, JULIAN · 2012 to 2016
$20.2M
COREPRESSOR REGULATION OF THYROID HORMONE ACTIONR01DK056123 · NIDDK · WEILL MEDICAL COLL OF CORNELL UNIV · PI HOLLENBERG, ANTHONY N · 2000 to 2023
$7.6M
INTEGRATED ENDOCRINE &METABOLIC RESEARCH TRAININGT32DK007516 · NIDDK · BETH ISRAEL DEACONESS MEDICAL CENTER · PI BARBARA B. KAHN · 1986 to 2026
$6.8M
Role of SMRT and NCoR in adipocyte differentation and functionR01DK078125 · NIDDK · UNIVERSITY OF CHICAGO · PI COHEN, RONALD N · 2008 to 2012
$1.5M
Corepressor Regulation of Nuclear Receptor ActionR56DK056123 · NIDDK · BETH ISRAEL DEACONESS MEDICAL CENTER · PI HOLLENBERG, ANTHONY N · 2009 to 2009
$425k
Role of SMRT and NCoR in adipocyte differentiation and functionR56DK078125 · NIDDK · UNIVERSITY OF CHICAGO · PI COHEN, RONALD N · 2007 to 2007
$115k
NCATS NIH HHS UL1 TR000430NIDDK NIH HHS DK056123NIDDK NIH HHS DK078125NIDDK NIH HHS P30 DK020595NIDDK NIH HHS R01 DK056123NIDDK NIH HHS R01 DK078125NIDDK NIH HHS R56 DK056123NIDDK NIH HHS R56 DK078125NIDDK NIH HHS T32 DK007516
6 · The paper itself

Abstract

NCoR1 (nuclear receptor corepressor) and SMRT (silencing mediator of retinoid and thyroid hormone receptors; NCoR2) are well-recognized coregulators of nuclear receptor (NR) action. However, their unique roles in the regulation of thyroid hormone (TH) signaling in specific cell types have not been determined. To accomplish this we generated mice that lacked function of either NCoR1, SMRT, or both in the liver only and additionally a global SMRT knockout model. Despite both corepressors being present in the liver, deletion of SMRT in either euthyroid or hypothyroid animals had little effect on TH signaling. In contrast, disruption of NCoR1 action confirmed that NCoR1 is the principal mediator of TH sensitivity in vivo. Similarly, global disruption of SMRT, unlike the global disruption of NCoR1, did not affect TH levels. While SMRT played little role in TH-regulated pathways, when disrupted in combination with NCoR1, it greatly accentuated the synthesis and storage of hepatic lipid. Taken together, these data demonstrate that corepressor specificity exists in vivo and that NCoR1 is the principal regulator of TH action. However, both corepressors collaborate to control hepatic lipid content, which likely reflects their cooperative activity in regulating the action of multiple NRs including the TH receptor (TR).

Indexed as

AnimalsLipidsMiceNuclear Receptor Co-Repressor 1Nuclear Receptor Co-Repressor 2Receptors, Cytoplasmic and NuclearReceptors, Thyroid HormoneSignal TransductionThyroid HormonesLipidsNuclear Receptor Co-Repressor 1Nuclear Receptor Co-Repressor 2Receptors, Cytoplasmic and NuclearReceptors, Thyroid HormoneThyroid Hormones

Identifiers

PMID25421714
PMCPMC4285426
OpenAlexW2142555552

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.